Fig. 2From: Efficacy and immunogenicity of insulin biosimilar compared to their reference products: a systematic review and meta-analysisChange of fasting plasma glucose (laboratory or self-monitoring of blood glucose) (mmol/L) at 24–52 weeksBack to article page